PRE-EXPOSURE PROPHYLAXIS DRUG ASSISTANCE PROGRAM (PrEPDAP)

The Massachusetts Pre-Exposure Prophylaxis Drug Assistance Program (PrEPDAP) helps Massachusetts residents pay for approved medications that can prevent the transmission of HIV. The program assists clients in need by covering out-of-pocket costs for Truvada (tenofovir/emtricitabine), including copays, co-insurance, and up-to-full-cost payments toward a deductible. PrEPDAP can also cover the full cost of Truvada, if necessary, for individuals who lack health insurance.

Truvada is a medication that has been shown to significantly reduce the likelihood of transmission of HIV between individuals and is the only FDA-approved medication for use as pre-exposure prophylaxis for HIV (PrEP).

PrEPDAP is a program of the Office of HIV/AIDS in the Bureau of Infectious Diseases at the Massachusetts Department of Public Health and is administered by Community Research Initiative (CRI).

For more information about PrEPDAP, please contact Kevin Herwig, Coordinator of PrEP + PEP Programs, at 617.502.1700 or kherwig@crine.org